Sodium Bicarbonate Injection Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Injection

Available Strengths: 8.4% (1 mEq/mL)

Reference Brands: Sodium Bicarbonate Injection

Category: Critical Care

Sodium Bicarbonate IV (4.2% & 8.4%) is widely used in emergency care for acidosis and cardiac arrest. Leading brands include Pfizer, Fresenius, and B. Braun. Pharma B2B platforms ensure dependable bulk supply of Sodium Bicarbonate injection for hospitals, ICUs, and life-saving critical care environments in US and EU markets. Sodium Bicarbonate Injection is available in Intravenous (IV) Injection and strengths such as 8.4% (1 mEq/mL). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sodium Bicarbonate Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Sodium Bicarbonate Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Sodium Bicarbonate is an essential alkalinizing agent used in emergency and critical care to treat metabolic acidosis, cardiac arrest, hyperkalemia, and certain drug overdoses. It is most commonly administered as an IV solution in 4.2% or 8.4% concentrations. Key brands include Pfizer, Fresenius Kabi, Hospira, and B. Braun, with available formats including vials, ampoules, and prefilled syringes. Sodium Bicarbonate IV is a life-saving hospital medicine, especially in ICUs and emergency departments. Pharma B2B platforms offer reliable, large-scale procurement of Sodium Bicarbonate solutions, supporting continuous supply for healthcare institutions across the US, EU, and other regulated global markets.